| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/30/2009 | WO2009093408A1 Methods for gene transfer to mammals |
| 07/30/2009 | WO2009093384A1 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof |
| 07/30/2009 | WO2009093288A1 Marker gene for examining psoriasis vulgaris |
| 07/30/2009 | WO2009093253A2 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression |
| 07/30/2009 | WO2009093242A2 Cell populations for polypeptide analysis and uses of same |
| 07/30/2009 | WO2009093201A2 Method for regulating agrobacterium-mediated transformation |
| 07/30/2009 | WO2009093200A2 Production of progenitor cereal cells |
| 07/30/2009 | WO2009093142A1 Method for the extraction and purification of nucleic acids on a membrane |
| 07/30/2009 | WO2009093138A1 Humanized antibodies specific for von willebrand factor |
| 07/30/2009 | WO2009093118A1 Cell surface display of proteins |
| 07/30/2009 | WO2009092925A2 Production of cleistogamic plants |
| 07/30/2009 | WO2009092790A1 Listeria monocytogenes cytotoxin listeriolysin s |
| 07/30/2009 | WO2009092772A2 Plants having enhanced yield-related traits and a method for making the same |
| 07/30/2009 | WO2009092727A1 Production of non-ribosomal peptides in saccharomyces |
| 07/30/2009 | WO2009092171A1 Compositions and methods for detecting juvenile renal dysplasia or calcium oxalate stones in dogs |
| 07/30/2009 | WO2009076400A3 Compositions and methods for inhibiting expression of factor vii gene |
| 07/30/2009 | WO2009075882A3 Impaired wound healing compositions and treatments |
| 07/30/2009 | WO2009071082A3 Rna antagonist compounds for the modulation of pik3ca expression |
| 07/30/2009 | WO2009067580A3 Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants |
| 07/30/2009 | WO2009067569A3 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof |
| 07/30/2009 | WO2009067243A3 Modulation of cd40 expression |
| 07/30/2009 | WO2009052426A3 Oncolytic virus |
| 07/30/2009 | WO2009050730A3 Rnai mediated knockdown of numa for cancer therapy |
| 07/30/2009 | WO2009045550A3 System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 07/30/2009 | WO2009042115A3 Methods of designing short hairpin rnas (shrnas) for gene silencing |
| 07/30/2009 | WO2009009798A3 Allelic exchange mutagenesis in map |
| 07/30/2009 | WO2008151636A8 Synthesis of mycophenolic acid (mpa) |
| 07/30/2009 | WO2008151150A3 Peg-pei copolymers for nucleic acid delivery |
| 07/30/2009 | WO2008150814A8 Methods for production and uses of multipotent cell populations |
| 07/30/2009 | WO2008148298A8 Improvement of cold tolerance in plants by protein kinase gene oscipk03 from rice |
| 07/30/2009 | WO2008147438A3 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| 07/30/2009 | WO2008145013A8 Fusion protein comprising targeting peptide of cd13 and lidamycin |
| 07/30/2009 | WO2008141523A8 A strain capable of producing arginine deiminase and the use thereof |
| 07/30/2009 | WO2008140887A8 Nucleotidyltransferases with enhanced nucleotide triphosphate flexibility |
| 07/30/2009 | WO2008109686A8 Non- infectious recombinant virus-like particles and their pharmaceutical applications |
| 07/30/2009 | WO2008109352A8 Nucleic acid compounds for inhibiting akt gene expression and uses thereof |
| 07/30/2009 | WO2008101406A8 Modified mutant collagenase and it's use in fat melting and in scar reduction |
| 07/30/2009 | WO2008098181A8 In vivo genome-wide mutagenesis |
| 07/30/2009 | WO2008094986A8 Bacterial leader sequences for increased expression |
| 07/30/2009 | WO2008093326A8 Control of so2 metabolism in plants and its applications |
| 07/30/2009 | WO2008090263A8 Preli - a novel t-cell regulator |
| 07/30/2009 | WO2008065200A8 Dnase expression in recombinant host cells |
| 07/30/2009 | WO2008040155A8 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/30/2009 | WO2008036953A8 In vivo transformation of pancreatic acinar cells into insulin-producing cells |
| 07/30/2009 | WO2008030996A8 Sirna and methods of manufacture |
| 07/30/2009 | WO2007147011A8 Polynucleotide therapy |
| 07/30/2009 | WO2007121522A8 Pestivirus species |
| 07/30/2009 | WO2007118935A8 Enzyme fusion proteins and their use |
| 07/30/2009 | WO2007112753A8 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| 07/30/2009 | WO2007112682A8 Recombinant human parathyroid hormone-related proteins and uses thereof |
| 07/30/2009 | WO2007104263A8 An enhancin of hepatitis b virus vaccine and its gene |
| 07/30/2009 | WO2007103738A8 Compositions related to the quantitative trait locus 6 (qtl6) in maize and methods of use |
| 07/30/2009 | WO2007087567A8 Antifungal polypeptides |
| 07/30/2009 | WO2007085923A8 Novel fluorescent proteins and methods for using same |
| 07/30/2009 | WO2007083226A8 Method for selecting a peptide or polypeptide which binds to a target molecule |
| 07/30/2009 | US20090193544 can effectively drive the expression of heterologous genes in mushroom such as Pleurotus ostreatus |
| 07/30/2009 | US20090193543 Plants Having Increase Yield and Method for Making the Same |
| 07/30/2009 | US20090193542 Brassica indehiscent1 sequences |
| 07/30/2009 | US20090193541 High level expression and accumulation of heterologous polypeptide in plant tissue |
| 07/30/2009 | US20090193540 Transgenic plant comprising vector coding Peronospora parasitica protein (PPR1) protein for propagating disease resistant plants; biological pest control; progenitor cells a vector is introduced into plant, growing a transgenic plant that expresses the nucleotide sequence |
| 07/30/2009 | US20090193539 Generation of plants with improved pathogen resistance |
| 07/30/2009 | US20090193537 Pea line crescendo |
| 07/30/2009 | US20090193536 Pea line 08240773 |
| 07/30/2009 | US20090193534 Transforming oviduct tissue of birds with nucleotide sequences coding mammalian polypeptides; tissue engineering |
| 07/30/2009 | US20090193533 Conditional-Stop Dimerizable Caspase Transgenic Animals |
| 07/30/2009 | US20090193531 Methods and compositions for RNA Interference |
| 07/30/2009 | US20090193530 Animals, cells and methods for production of detectably-labeled antibodies |
| 07/30/2009 | US20090192304 Nucleic acid for acetolactate synthase, acetolactate synthase regulatory regions, alpha-tubulin promoter, a promoter from a Thraustochytriales polyketide synthase system, and fatty acid desaturase promoter; used for the expression of foreign nucleic acids and mutations in the microorganism |
| 07/30/2009 | US20090192295 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 07/30/2009 | US20090192294 Magi polynucleotides, polypeptides, and antibodies |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192291 Production of homotrimeric fusion proteins |
| 07/30/2009 | US20090192290 New bacillus thuringiensis strains and their insecticidal proteins |
| 07/30/2009 | US20090192193 Diagnostic agent and method for detection of cancer and a means for treatment of same |
| 07/30/2009 | US20090192118 Tak1-d mediated induction of cell death in human cancer cells by specific sequence short double-stranded rnas |
| 07/30/2009 | US20090192114 miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 07/30/2009 | US20090192113 Interfering RNA Duplex Having Blunt-Ends and 3`-Modifications |
| 07/30/2009 | US20090192111 miR-124 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 07/30/2009 | US20090192110 Rna antagonist compounds for the modulation of pik3ca expression |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192108 Gene overexpressed in cancer |
| 07/30/2009 | US20090192106 MODULATION OF eIF4E EXPRESSION |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192104 RNA INTERFERENCE MEDIATED INHIBITION OF HYPOXIA INDUCIBLE FACTOR 1 (HIF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/30/2009 | US20090192103 Multitargeting Interfering RNAs Having Two Active Strands And Methods For Their Design And Use |
| 07/30/2009 | US20090192102 miR-21 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 07/30/2009 | US20090192100 Novel use of spiegelmers |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192087 Methods and Compositions Using Klotho-FGF Fusion Polypeptides |
| 07/30/2009 | US20090192074 Methods and pharmaceutical compositions for healing wounds |
| 07/30/2009 | US20090192039 Wheat plants having increased resistance to imidazolinone herbicides |
| 07/30/2009 | US20090191650 Diagnosing alzheimer's disease via presence of variant brain membrane protein |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191636 Method of Producing Transgenic Graminaceous Cells and Plants |
| 07/30/2009 | US20090191625 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 07/30/2009 | US20090191624 Use of transthyretin peptide/protein fussions to increase the serum half-life of pharmacologically active peptides/proteins |
| 07/30/2009 | US20090191623 Pseudomonas aeruginosa azurin, and/or Pseudomonas aeruginosa cytochrome c551; capable of binding to one or more targets selected from CD4, gp120, ICAM-3, and DC-SIGN |
| 07/30/2009 | US20090191622 Synthetic nucleic acids from aquatic species |
| 07/30/2009 | US20090191619 Method and device for selectively targeting cells within a three-dimensional specimen |
| 07/30/2009 | US20090191611 Methods and Compositions for the Treatment of Gastrointestinal Disorders |